Adult 400/100 mg (two 200/50 mg tab or 5 mL oral soln) bd or 800/200 mg (four 200/50 mg tab or 10 mL oral soln) once daily in patients w/ <3 lopinavir-associated mutations. Should not be administered once daily in combination w/ carbamazepine, phenobarb or phenytoin.
Childn 6 mth-12 yr weighing >40 kg 400/100 mg (two 200/50 mg tab or 5 mL oral soln) bd,
15-40 kg 10/2.5 mg/kg bd,
7 to <15 kg 12/3 mg/kg bd.
Concomitant therapy w/ efavirenz, nevirapine, amprenavir or nelfinavir Adult 400/100 mg bd w/ no adjustment in antiretroviral-naïve patients. May be increased to 6.5 mL oral soln bd in treatment-experienced patients where decreased susceptibility to lopinavir is clinically suspected. Should not be administered as once-daily regimen in combination w/ efavirenz, nevirapine, amprenavir or nelfinavir.
Pregnant patient w/ no documented lopinavir-associated resistance substitutions 400/100 mg tab bd.
Concomitant therapy w/ efavirenz, nevirapine or amprenavir Childn 6 mth-12 yr weighing >45 kg Max: 533/133 mg bd;
15-45 kg 11/2.75 mg/kg bd;
7 to <15 kg 13/3.25 mg/kg bd.